drugset / Trial / NCT00770952
Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the effect of pioglitazone, once daily (QD), and glimepiride combination therapy compared to glimepiride monotherapy in subjects with Type 2 Diabetes.
Timeline
- Start
- 2006-12
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glimepiride | Small molecule | 4 mg | Oral |
| Subject | Glimepiride | Small molecule | 6 mg | Oral |
| Subject | Pioglitazone | Small molecule | 45 mg | Oral |